Safety and immunogenicity of four sequential doses of NVX-CoV2373 in adults and adolescents: a phase 3, randomized, placebo-controlled trial (PREVENT-19)
Germán Áñez, Alice McGarry, Wayne Woo, Karen L. Kotloff, Cynthia L. Gay, Mingzhu Zhu, Shane Cloney-Clark, Joy Nelson, Haoua Dunbar, Miranda R. Cai, Iksung Cho, Zhaohui Cai, Raj Kalkeri, Joyce S. Plested, Nita Patel, Katherine Smith, Anthony M. Marchese, Gregory M. Glenn, Raburn M. Mallory, View ORCID ProfileLisa M. Dunkle, the 2019CoVn-301 Study Investigators
doi: https://doi.org/10.1101/2024.11.07.24316930
